Primary Biliary Cholangitis PBMC
About: Primary Biliary Cholangitis PBMC samples are collected from clinically confirmed Primary Biliary Cholangitis (PBC) donors and cryopreserved. These PBMCs are ideal for investigating T cell response, B cell activity, and cytokine production.
| Lot Number | Condition | Cell Count (M) | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 73455 | Primary Biliary Cholangitis (Cirrhosis) | 10M | Hispanic/Latino | 44 | Female |
Ursodiol/500mg/TID Omeprazole/20mg/QD Zyrtec/10mg/QD Albuterol/PRN
|
2 | |||
| 73540 | Primary Biliary Cholangitis (Cirrhosis) | 10M | Caucasian | 56 | Female |
Ursodiol 1250mg total Ocaliva 10mg po qd Atorvastatin 40mg po qd Levothyroxine 150mcg po qd Pantoprozole 40mg po qd Rifampin 150mg po bid Calcium citrate 1200mg po qd
|
2 | |||
| 73724 | Primary Biliary Cholangitis (Cirrhosis) | 10M | Caucasian | 74 | Male | United States (US) |
Crestor 10mg po qd Lipitor 10mg po qd Metformin 500mg po bid Vit D 500IU po qd Ursodiol 500mg AM --> 250mg lunch -->500mg PM QD Ozempic injectable qweekly medical marijuana vaping out of cartridge
|
8 | ||
| 73690 | Primary Biliary Cholangitis (Cirrhosis) | 10M | Caucasian | 75 | Female | United States (US) |
Ursodiol 250 mg TID NOT on Ocaliva Topical ointment-Triamcinolone Acetonide 0.1% applied daily-pea sized amount.
|
3 | ||
| 73420 | Primary Biliary Cholangitis (Cirrhosis) | 10M | Caucasian | 63 | Female | United States (US) |
lisinopril 10 mg QD cytamil for throid 5 mcg BID np (armoer thyroid) 60 mg QD omeprazole 40 mg QD baby aspirin ursodiol 250 mg x2 BID
|
2 | ||
| 55916 | Primary Biliary Cholangitis (Cirrhosis) | 5M | Caucasian | 74 | Male | United States (US) |
Crestor 10mg po qd Lipitor 10mg po qd Metformin 500mg po bid Vit D 500IU po qd Ursodiol 500mg AM --> 250mg lunch -->500mg PM QD Ozempic injectable qweekly
|
6 | $891.00 | |
| 55896 | Primary Biliary Cholangitis (Cirrhosis) | 5M | Caucasian Hispanic/Latino | 44 | Female | United States (US) |
Ursodiol 600mg BID Carosate 1mg 4/day lemotrogen 200mg QD Wellbutrin 100mg BID prylosec 20mg QD Adidrax 25mg every 6 hours Bentyl 20mg QD
|
6 | $891.00 |
Primary Biliary Cholangitis PBMC for Research
Primary Biliary Cholangitis Human PBMC products are sourced from donors clinically diagnosed with Primary Biliary Cholangitis (PBC) and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies related to autoimmune liver damage including T cell response, B cell activity, and cytokine production.
Product Features
- Research Use Only (RUO), cryopreserved PBMCs
- Clinically confirmed PBC donors
- Available in cell counts ranging from 5 million to 2 billion
- Processed within 24 hours of collection
- Stored using CryoStor® CS10 freezing media
- IRB-approved protocols and electronic informed consent
- Screen LeukoLot™ available prior to bulk orders
De-identified Donor Data
- Verified PBC diagnosis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported allergies and infectious disease history
- Additional PBC-specific data available upon request
Applications
- Biomarker discovery and validation
- Drug screening and therapeutic development
- Immune pathway analysis in Primary Biliary Cholangitis (PBC) pathophysiology
- Transcriptomic and proteomic profiling
Quality and Compliance
- IRB-approved collections and protocols
- 21 CFR Part 11 – compliant e-consent system
- HIPAA-compliant donor data protection
Ordering & Shipping
Primary Biliary Cholangitis PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
PBMC
Frequently Asked Questions
1 Answer
Electronic medical records are an option to be included with the PBMC sample, as well as, flow cytometry and other phenotypic testing.
1 Answer
YES – we can often accommodate treatment-naive samples including various cancers, and you can specify immunosupression status or other requirements in the I/E criteria.
1 Answer
Self-reported infectious disease testing is always available and some of our products have additional testing.
1 Answer
HLA-typing is available for some of our PBMC products.
1 Answer
YES to both – Unique donors can be specified, and multiple vials from the same donor can be arranged. You can specify these requirements when ordering.
1 Answer
Healthy PBMCs achieve over 90% vialbity post-thaw. Although our disease-state PBMCs are processed with same stringent SOP, there is more variability depending upon disease. Learn more about our post thaw viability here. https://sanguinebio.com/pbmc-viability-quality-assurance/
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.